+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sterile Compounding Pharmacies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Injectable Drugs and Infusions) and Route of Administration (Intravenous, Intramuscular, and Subcutaneous), and Geography- Product Image
Sterile Compounding Pharmacies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Injectable Drugs and Infusions) and Route of Administration (Intravenous, Intramuscular, and Subcutaneous), and Geography- Product Image
Sale

Sterile Compounding Pharmacies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Injectable Drugs and Infusions) and Route of Administration (Intravenous, Intramuscular, and Subcutaneous), and Geography

  • PDF Icon

    Report

  • 163 Pages
  • December 2021
  • Region: Global
  • The Insight Partners
  • ID: 5547695
UP TO OFF until Dec 31st 2024
Description Jump to:
The sterile compounding pharmacies market is projected to reach US$ 6,198.59 million by 2028 from US$ 3,968.70 million in 2021; it is expected to grow at a CAGR of 6.6% from 2021 to 2028. On-site sterile compounding has gained significant attention in the market and is one of the most impacting factors responsible for the market growth. On-site compounding and sterilization can prove vital in case of an intravenous solution intended to be customized as per the patient's requirement. Also, compounding and filtering a formulation into a sterile intravenous solution is successfully met through strong collaboration with the pharmaceutical sponsor and clinical site pharmacists, where sterility testing can be conducted efficiently. Today, sterile compounding pharmacists are focusing on the latest research activities, innovative techniques, and quality control rules for getting the best ingredients that meet patients’ needs. For example, the National Association of Boards of Pharmacy (NABP) announced receiving funding from the Food and Drug Administration (FDA) for developing a data-sharing system that improves oversight of sterile compounding pharmacies. This new system is predicted to assist in collecting, managing, and sharing information related to sterile compounding, especially in the US. Moreover, the project also aims to reduce the risk of injury, favoring patients from drug products that have been improperly compounded.



The global sterile compounding pharmacies market is bifurcated on the basis of product and route of administration. Based on product, the market is bifurcated into injectable drugs and infusions. The injectable drugs segment would account for a larger market share during 2021-2028. Injectable drugs are among the most preferred sterile compounding products due to their faster mode of action. Additionally, major players are adopting new strategies for staying forefront in the global market. For instance, in February 2021, Fresenius Kabi Canada announced the launch of 'IDIACO', an adalimumab biosimilar in Canada. The drug is instantly available for all the reference medicine's indications in the field of rheumatology, gastroenterology, and dermatology. Moreover, in November 2020, Fagron, Inc. announced the launch of new platforms with multiple presentations available-IV Bags for the expansion of its product portfolio. The new platform launches with multiple presentations related to fentaNYL, HYDROmorphone, and Midazolam.

By route of administration, the sterile compounding pharmacies market is segmented into intravenous, intramuscular, and subcutaneous. The intravenous segment would dominate the market in the coming years. The intravenous route of the administration has a 100% bioavailability, which drives the market growth for the intravenous segment. Additionally, through the intravenous route, drugs can be delivered uniformly. Also, a large volume of infusion can be administered through the IV route. For instance, 20% mannitol is delivered in cases of cerebral edema by I.V. infusion. Such factors would support the growth of the sterile compounding pharmacies market for the intravenous segment during the forecast period.

The World Health Organization (WHO), Industrial Research Assistance Program, Good Manufacturing Practices, Organization for Economic Co-operation and Development and Quality Care Pharmacy Program are among the primary and secondary sources referred to while preparing the report on the sterile compounding pharmacies market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the sterile compounding pharmacies market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global sterile compounding pharmacies market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Sterile Compounding Pharmacies Market - By Product
1.3.2 Global Sterile Compounding Pharmacies Market - By Route of Administration
1.3.3 Global Sterile Compounding Pharmacies Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Sterile Compounding Pharmacies Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Sterile Compounding Pharmacies Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Uptake of Personalized Medicines
5.1.2 Benefits of On-site Sterile Compounding
5.2 Market Restraints
5.2.1 Product Recalls and Stringent Regulatory Requirements
5.3 Market Opportunities
5.3.1 Development of Centralized or Regional Compounding Centers for Customized Formulation
5.4 Future Trends
5.4.1 Continued Support for Outsourcing Facilities and Manufacturing
5.5 Impact Analysis
6. Sterile Compounding Pharmacies Market- Global Analysis
6.1 Global Sterile Compounding Pharmacies Market Revenue Forecast and Analysis
6.2 Global Sterile Compounding Pharmacies Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028- by Product
7.1 Overview
7.2 Global Sterile Compounding Pharmacies Market, By Product, 2021 & 2028 (%)
7.3 Injectable Drugs
7.3.1 Overview
7.3.2 Injectable Drugs: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Infusions
7.4.1 Overview
7.4.2 Infusions: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
8. Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 - Route of Administration
8.1 Overview
8.2 Global Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)
8.3 Subcutaneous
8.3.1 Overview
8.3.2 Subcutaneous: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
8.4 Intravenous
8.4.1 Overview
8.4.2 Intravenous: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
8.5 Intramuscular
8.5.1 Overview
8.5.2 Intramuscular: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
9. Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 - Geographical Analysis
9.1 North America: Sterile Compounding Pharmacies Market
9.1.1 Overview
9.1.2 North America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Sterile Compounding Pharmacies Market, by Product, 2019-2028 (US$ Million)
9.1.4 North America: Sterile Compounding Pharmacies Market, by Route of Administration, 2019-2028 (US$ Million)
9.1.5 North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Overview
9.1.5.1.2 US: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.3 US: Sterile Compounding Pharmacies Market, by Product, 2019-2028 (US$ Million)
9.1.5.1.4 US: Sterile Compounding Pharmacies Market, by Route of Administration, 2019-2028 (US$ Million)
9.1.5.2 Canada: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Overview
9.1.5.2.2 Canada: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.3 Canada: Sterile Compounding Pharmacies Market, by Product, 2019-2028 (US$ Million)
9.1.5.2.4 Canada: Sterile Compounding Pharmacies Market, by Route of Administration, 2019-2028 (US$ Million)
9.1.5.3 Mexico: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Overview
9.1.5.3.2 Mexico: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.3 Mexico: Sterile Compounding Pharmacies Market, by Product, 2019-2028 (US$ Million)
9.1.5.3.4 Mexico: Sterile Compounding Pharmacies Market, by Route of Administration, 2019-2028 (US$ Million)
9.2 Europe: Sterile Compounding Pharmacies Market
9.2.1 Overview
9.2.2 Europe: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
9.2.4 Europe: Sterile Compounding Pharmacies Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
9.2.5 Europe: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.4 Germany: Sterile Compounding Pharmacies Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
9.2.5.2 France: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 France: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 France: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.4 France: Sterile Compounding Pharmacies Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
9.2.5.3 UK: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 UK: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 UK: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.4 UK: Sterile Compounding Pharmacies Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
9.2.5.4 Italy: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.4 Italy: Sterile Compounding Pharmacies Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
9.2.5.5 Spain: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.4 Spain: Sterile Compounding Pharmacies Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
9.2.5.6 Rest of Europe: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Sterile Compounding Pharmacies Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
9.3 Asia Pacific Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028
9.3.1 Overview
9.3.2 Asia Pacific Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.3 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.3.4 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.3.5 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.3.5.1 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.1.3 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.3.5.1.4 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.3.5.2 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.2.1 Overview
9.3.5.2.2 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.2.3 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.3.5.2.4 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.3.5.3 India Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.3.3 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.3.5.3.4 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.3.5.4 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.4.1 Overview
9.3.5.4.2 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.4.3 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.3.5.4.4 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.3.5.5 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.5.1 Overview
9.3.5.5.2 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.5.3 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.3.5.5.4 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.3.5.6 Rest of Asia Pacific: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia Pacific: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.3.5.6.4 Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.4 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028
9.4.1 Overview
9.4.2 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.3 Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.4.5 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.4.5.1 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.1.1 Overview
9.4.5.1.2 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.1.3 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.4.5.1.4 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
9.4.5.2 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.2.1 Overview
9.4.5.2.2 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.2.3 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.4.5.2.4 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
9.4.5.3 South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.3.1 Overview
9.4.5.3.2 South Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.3.3 South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
9.4.5.4 Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.1 Overview
9.4.5.4.2 Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.3 Rest of Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
9.5 South and Central America: Sterile Compounding Pharmacies Market-Revenue and Forecasts To 2028
9.5.1 Overview
9.5.2 South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.5.3 South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)
9.5.4 South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.5.5 South and Central America: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
9.5.5.1 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)
9.5.5.1.1 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)
9.5.5.1.2 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)
9.5.5.1.3 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.5.5.2 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)
9.5.5.2.1 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)
9.5.5.2.2 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)
9.5.5.2.3 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
9.5.5.3 Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.1 Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.2 Rest of South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)
9.5.5.3.3 Rest of South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
10. Impact Of COVID-19 Pandemic on Sterile Compounding Pharmacies Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Sterile Compounding Pharmacies Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Sterile Compounding Pharmacies Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Fagron, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Triangle Compounding Pharmacy
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 B. Braun Melsungen AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PharMEDium Healthcare Holdings, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Avella specialty pharmacy
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pencol Compounding Pharmacy
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Pavilion Compounding Pharmacy, LLC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Pace Pharmacy
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 SandsRx
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Publisher
13.2 Glossary of Terms
List of Tables
Table 1. North America Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 9. Europe: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 10. Europe: Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany: Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain: Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe: Sterile Compounding Pharmacies Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Sterile Compounding Pharmacies Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 23. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million).
Table 24. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 25. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 26. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 27. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 28. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 29. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 30. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 31. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 32. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 33. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 34. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 35. Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 36. Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 37. Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 38. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 39. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 40. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 41. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 42. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 43. South Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 44. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 45. Rest of Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 46. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 47. South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecasts to 2028, By Product (US$ Million)
Table 48. South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 49. Brazil Sterile Compounding Pharmacies Market - Revenue and Forecasts to 2028, By Product (US$ Million)
Table 50. Brazil Sterile Compounding Pharmacies Market - Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 51. Argentina Sterile Compounding Pharmacies Market - Revenue and Forecasts to 2028, By Product (US$ Million)
Table 52. Argentina Sterile Compounding Pharmacies Market - Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 53. Rest of South and Central America Sterile Compounding Pharmacies Market - Revenue and Forecasts to 2028, By Product (US$ Million)
Table 54. Rest of South and Central America Sterile Compounding Pharmacies Market - Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 55. Organic Developments in the Sterile Compounding Pharmacies Market
Table 56. Inorganic Developments in the Sterile Compounding Pharmacies Market
Table 57. Glossary of Terms
List of Figures
Figure 1. Sterile Compounding Pharmacies Market Segmentation
Figure 2. Sterile Compounding Pharmacies Market, By Region
Figure 3. Global Sterile Compounding Pharmacies Market Overview
Figure 4. Injectable Drugs Segment Held Largest Share of Product Segment in Sterile Compounding Pharmacies Market
Figure 5. North America is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Sterile Compounding Pharmacies Market, by Geography (US$ Million)
Figure 7. Global Sterile Compounding Pharmacies Market- Leading Country Markets (US$ Million)
Figure 8. Global Sterile Compounding Pharmacies Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints About Sterile Compounding Pharmacies Market
Figure 16. Global Sterile Compounding Pharmacies Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 17. Global Sterile Compounding Pharmacies Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Sterile Compounding Pharmacies Market
Figure 19. Global Sterile Compounding Pharmacies Market, by Product, 2021 & 2028 (%)
Figure 20. Injectable Drugs: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Infusions: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Global Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)
Figure 23. Subcutaneous: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Intravenous: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Intramuscular: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. North America: Sterile Compounding Pharmacies Market, by Key Country – Revenue (2021) (US$ Million)
Figure 27. North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)
Figure 29. US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe: Sterile Compounding Pharmacies Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. Europe: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Europe: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)
Figure 35. Germany: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. France: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. UK: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Italy: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Spain: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Rest of Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Asia Pacific Sterile Compounding Pharmacies Market Overview, by Country (2021)
Figure 42. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 43. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 44. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 45. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 46. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 47. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 48. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 49. Rest of Asia Pacific: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Middle East & Africa Sterile Compounding Pharmacies Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 51. Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 52. Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 53. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 54. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 56. Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. South and Central America: Sterile Compounding Pharmacies Market, Revenue Overview, by Country, 2021 (US$ Million)
Figure 58. South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)
Figure 59. South and Central America: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)
Figure 60. Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)
Figure 61. Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)
Figure 62. Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Impact of COVID-19 Pandemic in North American Country Markets
Figure 64. Impact of COVID-19 Pandemic in European Country Markets
Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 66. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 67. Impact of COVID-19 Pandemic on Sterile Compounding Pharmacies Market in South and Central American Countries
Figure 68. Growth Strategies in the Sterile Compounding Pharmacies Market (%)

Companies Mentioned

  • Fagron, Inc.
  • Triangle Compounding Pharmacy
  • B. Braun Melsungen AG
  • PharMedium Healthcare Holdings, Inc.
  • Fresenious Kabi AG
  • Avella Specialty Pharmacy
  • Pencol Compounding Pharmacy
  • Pavilion Compounding Pharmacy, LLC.
  • Pace Pharmacy
  • SandsRx

Table Information

Report AttributeDetails
No. of Pages163
PublishedDecember 2021
Forecast Period2021 - 2028
Estimated Market Value ( USD ) in 2021 $ 3968.7 million
Forecasted Market Value ( USD ) by 2028 $ 6198.59 million
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Sterile Compounding Pharmacies Global Market Report 2024 - Product Image

Sterile Compounding Pharmacies Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 245 Pages
  • Global
Compounding Pharmacy - Global Strategic Business Report - Product Image

Compounding Pharmacy - Global Strategic Business Report

  • Report
  • 187 Pages
  • Global
From
Compounding Pharmacy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Compounding Pharmacy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.